Ads
related to: medicine, pharmaceuticals
Search results
CHMP approves backing for first acanthamoeba keratitis treatment
Pharmaceutical Technology via Yahoo Finance· 5 days agoAkantior has been awarded orphan drug status by both the EMA and the US Food...potassium hydrogen...
Job fair for university graduates held in Yunnan
China Daily· 1 hour agoA job fair for university graduates was held at Yunnan Minzu University, in Southwest China's Yunnan province on Wednesday, according to news portal ynet.com.
Watch Out Wegovy: Here Comes Another Promising Anti-Obesity Candidate
Motley Fool via Yahoo Finance· 4 days agoInvestors interested in the pharmaceutical industry are currently excited about the anti-obesity...
European pharma regulation changes signal tumult and transformation
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe two main tracks of regulation on everyone’s minds were the revised General Pharmaceutical...
Geron wins long-sought drug approval; Califf talks China, GLP-1s at BIO
BioPharma Dive via Yahoo Finance· 13 hours agoAfter 34 years, Geron finally has an approved medicine in Rytelo. Elsewhere, Shionogi disclosed...
Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) the Best Bet in Gene Therapy Industry?
Insider Monkey via Yahoo Finance· 4 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Veeva R&D Summit: Pharma companies need a say in AI regulation
Clinical Trials Arena via Yahoo Finance· 2 days ago“As a result, it is important that everyone works together to at least share our views on this.” In...
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Receives Buy Rating from Chardan Capital
ETF DAILY NEWS· 3 days agoArrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report)‘s stock had its “buy” rating reiterated by Chardan Capital in a research note issued on Monday, Benzinga reports.
TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
Zacks via Yahoo Finance· 3 days agoTeva Pharmaceutical Industries Limited’s TEVA revenues have suffered significantly since it lost...
Initial public offerings scheduled to debut next week
Houston Chronicle· 5 hours agoThe following is a list of initial public offerings planned for the coming week. Proposed Nasdaq symbol TEM. Business: Provides data and analytics tools for precision medicine. Proposed Nasdaq symbol TLX.
